Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Anoro Ellipta for Treatment of Chronic Obstructive Pulmonary Disease

Drug Name (Brand / Generic)

Anoro ellipta / umeclidinium bromide and vilanterol

Company / Licensee

GlaxoSmithKline (GSK) / Theravance

Product Description

Combination of a long-acting muscarinic antagonist (LAMA) and a long-acting beta agonist (LABA)

Current Indication

Chronic Obstructive Pulmonary Disease (COPD)

Market Sector

Respiratory

Development Status

Approved in the US, Japan and Europe
Expand
Close
Close
Close

Go Top